← Eichor
Study identifier: NCT05904340 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy

Condition: Breast Neoplasms · Chemotherapy-induced Peripheral Neuropathy  ·  Sponsor: National Taipei University of Nursing and Health Sciences

PhaseNA
Planned participants86
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Breast cancer ranks first in Taiwan's top ten gynecological cancers. Chemotherapy is a standard treatment method for colorectal cancer and breast cancer, but while destroying cancer cells, it also destroys healthy cells, resulting in side effects. Peripheral neuropathy can lead to peripheral nerve damage and decreased activity, which affects the patient's quality of life. Currently, there is no standard and effective method for treating peripheral neuropathy caused by chemotherapy. Therefore, the purpose of this study is to investigate the effect of percutaneous electrical acupoint stimulation on improving peripheral nerve symptoms in breast cancer patients undergoing chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

CHIA HAO YANG  ·  +886912631133  ·  henry1993110101@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Changhua Christian HospitalChanghua, Changhua, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05904340